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Summary Characterisation and quantitation of epidermal growth factor receptors (EGFR) have been carried
out on eight human squamous carcinoma cell lines and the results compared with those from simian virus
transformed keratinocytes and normal keratinocytes grown under similar conditions. All cells tested possess
both high and low affinity receptors with dissociation constants ranging from 2.4 x 10-10M to 5.4 x 10 -9M.
When epidermal growth factor (EGF) binds to its receptor it is internalised and degraded and the receptor is
down regulated. Malignant cells and virally transformed cells possess 5-50 times more EGF receptors than
normal keratinocytes and one cell line LICR-LON-HN-5 possesses up to 1.4 x 107 receptors per cell, which is
the highest number yet reported for a cell line. These results are discussed in the context of recent data that
suggest that the increased expression of EGF receptors in epidermoid malignancies may be an important
compotent of the malignant phenotype in these tumours.
Epidermal growth factor (EGF) is a polypeptide of
6,045 daltons which has been shown to be mito-
genic to both ectodermal cells (Cohen & Elliot,
1963; Carpenter & Cohen, 1979; Gospodarowicz,
1981) and endodermal cells (Konturek et al., 1981)
in vivo and which promotes growth of mesodermal
and ectodermal cells in vitro (Cohen & Elliot, 1963;
Gospodarowicz et al., 1978; Adamson & Rees,
1981; Rheinwald & Green, 1977). The physiological
effects of EGF on human epidermal cells, however,
are not clearly delinated, but appear to be poten-
tially involved in both growth and differentiation
(Gusterson et al., 1984).
EGF binds to a specific membrane receptor of
170,000daltons (Das et al., 1977) to activate a
tyrosine specific protein kinase which is part of the
intracellular domain of the receptor (Gill et al.,
1985). Binding data with radiolabelled EGF have
demonstrated that the number of binding sites in
the cell types studied is variable, but there are
usually two binding affinities one of which is of
high affinity Kd 10 1-M and a lower site of Kd
10 -9 M (Hunter & Cooper, 1981). Recently the gene
encoding the EGF receptor has been localised to
the short arm of chromosome 7 (Kondo &
Schimizu, 1983; Schimizu et al., 1984) and in
normal human cells encodes mRNA molecules of
10.1 and 5.8kilobases (kb) (Schimizu et al., 1984;
Ullrich et al., 1984).
In addition to its in vivo and in vitro effect on the
proliferation of skin and keratinocytes where it also
retards differentiation, (Carpenter & Cohen, 1979;
Rheinwald & Green, 1977) epidermal growth factor
appears to play an important role in the develop-
ment and regulation of a wide range of human
malignancies including glial tumours (Libermann et
al., 1985) bladder tumours (Gusterson et al., 1984)
breast carcinomas (Filmus et al., 1985; Fitzpatrick
et al., 1984) and epidermoid malignancies (Fabri-
cant et al., 1977; Cowley et al., 1984; Ozanne et al.,
1985). In previous reports we have briefly reported
the presence of increased levels of EGF receptors in
a number of cell lines derived from squamous cell
carcinomas of the head and neck (Cowley et al.,
1984; Ozanne et al., 1985). Here we report the
detailed analysis of the binding kinetics of the
receptor in these cell lines together with a compara-
tive analysis of normal keratinocytes and a simian
virus transformed keratinocyte cell line SVK14
(Taylor-Papadimitriou et al., 1982). These data thus
form the basis for detailed molecular studies to
investigate the mechanisms of the increased re-
ceptor levels together with analyses of their bio-
logical significance.
Materials and methods
Reagents
Mouse EGF was purified using high performance
liquid chromatography (HPLC) as previously de-
scribed (Smith et al., 1984). 125I-labelled EGF
(125I-EGF) was prepared by the chloramine T
method (Hollenberg & Cuatrecasas, 1975) to an
activity of 0.4-0.8 x 106 cpmpmol-1. HPLC analy-
sis of 125I-EGF showed it to present a profile
similar to that of the unlabelled material.
Cells and culture
The eight squamous carcinoma cell lines used in
this study were established from human tumours of
the oropharyngeal and laryngeal mucosa (Table I)
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Table I Number of EGF receptors
dissociation constants
per cell and
No. of
Dissociation receptorsl
Cell line constant (Kd) cell
3.8+1.8x10'10M 2.9+0.5x 104 Keratinocytes 3.8+ 1.3 x 10-9M 2.5+0.0x 105
SVK14 6.2+0.6x10`10M 3.9+0.4x 105
4.2+2.5 x 10 9M 1.6+0.4 x 106
LICR-LON-HN-1 3.00.4xx 10`M 2.8+0.1 x 105 LICR-LN-HN-1 2.9+0.1 x 10-9 M 3.9+0.3 x 105
LICR-LON-HN-2 3.3 + 0.7 x 10- 10M 2.2+0.1 x 105 2.0+0.0 x 10-9M 7.2+0.2 x 105
2.4+0.7x 10-10M 3.0+1.0x 105 LICR-LON-HN-3 2.8+0.1 x 10-9M 1.7+0.3 x 106
LICR-LON-HN-4 1.3 +0.3 x 10-9M 5.3+0.1 x 105 4.3+0.7 x 10 9M 1.5+0.1 X 106
LICR-LON-HN-5 4.2+0.5x10-10M 1.4+0.0x 106 5.4+0.6x 10 9M 1.3+0.2x 107
LICR-LON-HN-6 3.6±0.0x10-1'M 2.6+0.1 x 105 2.2+0.2 x 10 9M 1.0+0.0 x 106
LICR LON HN6Rr 7.8+ 2+2 x 10'0 M 6.2+ 1.4 x 105 LICR-LON-HN-6Rr 2.8+0.5 x i0- 9m 1.5 +0.1 X 106
LICR-LON-HN-6nL 2.5±0.5 x 10-10 m 1.4+0.6 xi05 3.5+0.7 x 10-9M 8.5 +0.5 x 105
LICR-LON-HN-10 6.5+ 0.5x 1010M 5.1+1.3x i05 4.1+0.1 x 109m 2.0+0.1 X 106
Each result is the mean of two separate binding assays.
(Easty et al., 198la,b). SV40 transformed keratino-
cytes (SVK14) were a gift from Dr Joyce Taylor-
Papadimitriou (Taylor-Papadimitriou et al., 1982).
Cultured cells were maintained in Dulbecco's
modified Eagle's medium (DMEM) with 10%
foetal calf serum, 100mg1 l minocyclin, 100mg 1-l
kanamycin and 2.5mgl-1 amphotericin B,
(DMEM) in 10% C02, 90% air.
Keratinocytes were prepared from normal adult
human skin as previously described (Cowley et al.,
1983). Briefly epithelial sheets were prepared from
skin obtained from reduction mammoplasty
specimens by collagenase (Sigma, Type lA)
digestion (0.25%) overnight. The epidermal cells
were then made into a single cell suspension using
(0.1%) trypsin (Sigma 1 1-S) in EDTA and
plated in 25cm2 flasks (Nunc) at a concentra-
tion of 4 x 106cells/25cm2. The cells reached
confluence after 5-7 days and were subcultured
into 24 well culture dishes at a density to reach
confluence 2-5 days after seeding. The cells were
grown in RPMI medium containing 15% foetal
calf serum; 50ngml - Cholera Toxin (Sigma),
0.4,ugml-1 hydrocortisone (Sigma), 100mgl-l
penicillin and antibiotics as above, buffered to
pH 7.4 with 5% C02, in air. Prior to use in assays,
keratinocytes were exposed to the same medium as
the other cell lines, for at least 48h.
Binding studies andprocessing ofEGF
Binding studies were performed on confluent mono-
layers in 24 well culture dishes (Colstar), 2-5 days
after seeding. Each well contained 1-5 x 105 cells
depending upon the cell line or cell strain used.
Cells were washed twice and incubated for 1 h in
Hepes-buffered culture medium 199, containing
0.1% bovine serum albumin (BSA) prior to carry-
ing out the binding assays. The binding was per-
formed in 0.5ml ofmedium 199 plus BSA. All assays
were carried out in triplicate. For Scatchard analy-
sis 125I-EGF was used over the range of 0.04 to
3.1 pmol. Nonspecific binding was measured in the
presence of excess unlabelled EGF (0.5ignml-1).
The nonspecific binding was consistently <3% of
the total on the cell lines, and on the keratinocytes
< 10%. At the completion of incubation, cells were
washed 3 times in medium 199 plus 0.1% BSA,
solubilised in 0.5% SDS in 1 M NaOH and their
radioactivity determined. All experiments were per-
formed at 4°C unless otherwise stated. Determin-
ation of numbers of binding sites and dissociation
constants was by Scatchard analysis, and best fitt-
ing lines were determined by linear regression.
Specific binding was determined by subtracting
nonspecific binding from total bound. Free 125F1
EGF was determined by subtracting the total
bound from the amount added initially.
The effect of 2mM chloroquine on the binding
was determined over a six hour time course using
the same protocol as described above.
Time course ofbinding at 4°C and 37°C
Cells were incubated in medium 199 plus 0.1%
BSA for 1 h and cooled to 4°C for subsequent
measurements at the lower temperature. Binding
assays were carried out as described above. 1251-
EGF (0.8 x 106cpm/well, 0.88pmol) in 0.5ml
medium 199/0.1% BSA was added to each well.
Every fourth well also received 0.5 jg unlabelled
EGF. At the end of incubation for each time point
triplicate cultures were washed, solubilised and
counted.
Effects of chloroquine on processing of 125I-EGF at
370C
Chloroquine (Sigma) at a final concentration of
0.2mM in medium 199 plus 0.1% BSA, was added
to cells in 24 well culture dishes with 125I-EGF
(0.8 x 106cpm/well, 0.88pmol); controls omitted theEGF RECEPTORS AND SQUAMOUS CARCINOMAS 225
chloroquine. Incubation was at 37°C, and triplicate
cultures were washed, solubilised and counted over
a 6-hour time course. Three wells of each cell type
were counted at the end of the experiment. As an
estimate of internalisation, separate identical cul-
tures were incubated with 0.1% trypsin at 37°C for
5-10min. Radioactive material released by trypsin
and that remaining with the cells was determined.
Measurement ofdegradation
12II-EGF (2.5ml 1.1pmolml-1; lx lO6cpmml-')
was incubated for 3h at 37°C with LICR-LON-
HN-5 cells, keratinocytes and SVK14 cells in
25cm2 flasks (Nunc). As a control, medium condit-
ioned by exposure to a parallel flask of cells was
incubated with 125I-EGF and treated similarly.
HPLC chromatograms of 1ml fractions of incu-
bated medium were run on an ultrapore RPSC (C)
column (Beckman Ltd. 7.5cm x4.6mm i.d. 5 par-
ticle size). 0.155 NaCl (pH2.1) was the primary
solvent, acentonitrile was the secondary solvent.
The following programme was used: 2.5min with
NaCl alone then a gradient of 2.0% acetonit-
rilemin - I for 2.5min; and 0.75% acetonitrilemin-1
thereafter, with a flow rate of 1 mlmin-1. One ml
fractions were collected and counted on a
gammacounter.
Down regulation ofEGF receptors
Triplicate confluent multi-well cultures were grown
for 24h in DMEM, either with or without
50ngml-1 EGF. After incubation, all cells were
washed in medium 199/0.1% BSA and then incu-
bated in medium 199/0.1% BSA (3 x 2h) for a total
of 6h. Cell cultures were then cooled to 4°C and
incubated for 4h in lml 1251I-EGF (1.7xl5 1 cpm,
0.2pmol) in medium 199/0.1% BSA. A fourth well
also contained 0.5,ug of unlabelled EGF for measu-
rement of non-specific binding. The amount of
125I-EGF bound specifically was determined as
above.
Results
Provisional studies comparing the binding of EGF
at 37TC and 4°C in the squamous carcinoma cell
lines and the SVK14 cells and normal keratinocytes
(Figure 1) demonstrated an increased binding in the
transformed cells at 37°C. Experiments involving
incubation in the presence of chloroquine, a known
inhibitor of EGF degradation (McKanna et al.,
1979), however, indicated that part of the binding
seen at 37°C represented internalised EGF with
subsequent degradation (Figure 2). Such degrad-
ation was confirmed by chromatography (Figure 3).
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Figure 1 Time course of binding of 1251-EGF at 4°C
and 37°C. Each time point represents the mean value
for 3 wells, minus non-specific binding in the presence
of excess unlabelled EGF. In these experiments each
well contained 5 x 105 normal keratinocytes (a) and
1.5 x 105 HN-5 tumour cells (b).
On the basis of these results all analyses of surface
receptor density were carried out at 4°C when
internalisation would be predicted to be inhibited
(Willingham & Pastan, 1982), and thus the closest
approximation to total surface receptor number
could be made. With all cells examined at 4°C
binding approached equilibrium after 4h; these
conditions were used for all subsequent assays.
Scatchard analysis (Figure 4) was carried out on
the data. Normal keratinocytes, SVK14 cells and
the tumour cell lines all had both high and low
affinity receptors with dissociation constants in the
range of 10-9 to 10-10M (Table I). The tumour
cells had 5-50 times the number of high and low
affinity receptors of normal keratinocytes with
LICR-LON-HN-5 cells having a total of 1.4x 107
sites per cell.
It is unlikely that the observation of two different
binding affinities present on each cell line was a
result of differential iodination or oxidation of
EGF during the labelling procedure, as a breast cell
line, assayed for receptors, possessed a binding of
single affinity using the same material (Cowley,
1984).
125I-EGF is internalised and transported to lyso-
somes where it is degraded. Chloroquine inhibits
I
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Figure 2 Effects of chloroquine on processing 1251_
EGF at 37°C. Controls omitted the chloroquine
(broken line). In these experiments each well contained
2 x 105 SVK14 cells (a); 4 x 105 normal keratinocytes
(b) and 1.4 x 105 HN-5 tumour cells (c).
this degradation and allows accumulation of the
growth factor within the cells. In these experiments
there is obviously accumulation of EGF in the
presence of chloroquine demonstrating that the
EGF does not only bind but is internalised. In HN-
5 cells, the amount of trypsin-insensitive cell-
associated radioactivity increased by 40% after
chloroquine treatment, whilst the trypsin-sensitive
binding increased by 10%. There is no obvious
difference in the proportion of EGF accumulated in
the presence of chloroquine in the tumour cells and
transformed cells compared with normal keratino-
cytes.
HPLC analysis of 125I-EGF degradation by HN-
5 cells is presented in Figure 3. A similar pattern of
degradation was also seen with normal keratino-
cytes. No degradation occurred in conditioned
medium in the absence of cells, demonstrating that
degradation on EGF was a cell-dependent process.
Down regulation of receptors was demonstrated
after pre-incubation overnight with unlabelled EGF
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Figure 3 HPLC analysis of 1251-EGF degradation by
HN-5 cells. One ml fractions of the HPLC eluate were
counted and results are plotted as counts against time
(min). The broken line represents the HPLC profile of
125I-EGF standard with a small free iodine peak after
3min and the main peak eluting at 24min. The solid
line represents the profile after incubation with HN-5
tumour cells. The gradient in CH3CN applied to the
column is shown (
(Table II). The degree of down regulation after 24h
was similar for the HN-5 cells, SVK14 and normal
keratinocytes, showing a drop of 50-60% in the
total amount of EGF specifically bound.
Thus all cell lines exhibited high and low affinity
EGF receptors which were demonstrated to be
down regulated by exogenous EGF in the case of
the cell line HN-5, SVK14 cells and normal
keratinocytes. The increased binding in the presence
of chloroquine at 37°C and the effects of temper-
ature supported the view that the binding seen at
37°C was a combination of surface binding, inter-
nalisation and degradation.
Table II Down regulation of EGF receptors
Counts bound (cpm)
with 50ng without %0 Down
Cell line EGF EGF regulation
LICR-LON-HN-5 36,238 71,295 51.0%
SVK14 5,302 10,827 49.0%
Keratinocytes 1,865 3,205 58.2%
Each well contained 1.2 x 10i HN-5 cells, 2.1 x 105
SVK14 cells or 2.2 x 105 keratinocytes. The mean specific
binding from 3 wells is shown.
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Figure 4 Binding of 125I-EGF to SVK14, keratinocytes, HN-5 and HN-10 cells. The standard binding assay
was performed at 4°C as described previously. Each point represents the average of 3 wells minus non-specific
binding. Results are srawn as Scatchard plots, allowing extrapolation to obtain numbers of receptors per cell
and dissociation constant (See Table I). 1.4 x 105 SVK cells/well (a); 1.7 x 105 normal keratinocytes/well (b);
0.9 x 105 HN-5 from cells/well (c); 1.1 x 105 HN-10 tumour cells/well (d).
Discussion
Original observations on the vulval epidermoid
carcinoma cell line A431 (Fabricant et al., 1977)
demonstrated raised levels of EGF receptors
(2-3 x 106/cell) greater than any line previously
reported. The gene for the receptor was
subsequently found to be amplified and translocated
(Schimizu et al., 1984; Ullrich et al., 1984).
The data presented here demonstrates that high
levels of EGF receptor are a common feature of
epidermoid carcinomas in vitro. Both carcinoma cell
lines and simian virus transformed cells have
similar capabilities to normal keratinocytes in terms
of their ability to internalise, their sensitivity to
chloroquine and their ability to degrade epidermal
growth factor. The binding kinetics for all cells
examined showed the typical pattern of a high and
low affinity receptor with dissociation constants of
10-10M and 1-9M respectively.
Recent immunocytochemical techniques and a
competitive binding assay utilising the monoclonal
antibody EGFR-1 have shown that the increased
receptor levels may be a constant feature of squa-
mous carcinomas from the lung, head and neck,
skin and cervix (Cowley et al., 1984; Ozanne et al.,
1985). Concerning the mechanisms underlying the
increased expression, studies on two of the cell lines
described here show gene amplification and in
another there is a specific translocation (Ozanne et
al., 1985). Studies on some breast cell lines have
also demonstrated increased EGF receptor levels
which are associated with amplification (Filmus et
al., 1985) and other tumours such as gliomas have
been reported to have amplified genes (Libermann
et al., 1985).
EGF is known to be mitogenic on keratinocytes
both in vivo and in vitro. In the case of epidermal
carcinomas the high levels of EGF receptor could
be envisaged as a potential mechanism whereby the
tumours can respond to levels of EGF in the
surrounding environment which are not mitogenic
to normal cells. Support for this view is found with
the epidermoid carcinoma cell line A431 which is
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stimulated to proliferate by levels of EGF which are
insufficient to stimulate normal keratinocytes
(Cowley et al., 1984; Kawamoto et al., 1983). The
low levels of EGF required to stimulate prolifera-
tion could also be produced by partial occupancy
of the receptor by a ligand produced by the cells
such as an a-TGF like molecule thus producing a
potentially autocrine mechanism (Sporn & Todaro,
1980).
The increased levels of receptor seen in the SV40
transformed cells may reflect their origin from a
minor population of cells with high receptor levels
combined with an inability of the cells to
differentiate in culture. An alternative explanation
is that the increased levels reflect the transformed
phenotype of the cells as a stage in neoplastic
progression.
There was no obvious correlation between the
doubling times of the cell lines and the binding data
(unpublished observation) supporting the view that
the differences in receptors were due to an overall
increase in receptor density rather than reflecting
those cultures with a high proportion of cells in
mitosis. There was also no correlation with ana-
plasia, the cell line with the highest levels, LICR-
LON-HN-5 having been demonstrated to keratinise
in culture with spinous cells, keratohyaline granule
containing cells and the formation of a cornified
envelope (Monaghan et al., 1983; Knight et al.,
1984) while the line LICR-LON-HN-2 with ten-fold
fewer receptors is relatively poorly differentiated
both in vitro and in vivo (Easty et al., 1981a;
Cowley et al., 1984).
Future analyses of the cell lines both at the
molecular and the cell biological level will aid our
understanding of both normal growth control and
the aberrations that occur in malignancy. The data
to date would suggest that increased levels of EGF
receptor may well be an important component of
the malignant phenotype in this cell type, but this is
probably only one component of a complex picture
of growth control in epithelial cells.
We would like to thank Drs M. Ellison and J. Ham who
initiated these studies. We would like to aknowledge the
donation of the SV40 transformed keratinocytes SVK14
by Dr Joyce Taylor-Papadimitriou of the Imperial Cancer
Research Fund.
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